Literature DB >> 24058175

Role of the Igh intronic enhancer Eμ in clonal selection at the pre-B to immature B cell transition.

Cheng Peng1, Laurel A Eckhardt.   

Abstract

We previously described a checkpoint for allelic exclusion that occurs at the pre-B cell to immature B cell transition and is dependent upon the IgH intronic enhancer, Eμ. We now provide evidence that the breach in allelic exclusion associated with Eμ deletion results from decreased Igμ levels that make it difficult for emerging BCRs to reach the signaling threshold required for positive selection into the immature B cell compartment. We show that this compartment is smaller in mice carrying an Eμ-deficient, but functional, IgH allele (VHΔ(a)). Pre-B cells in such mice produce ≈ 50% wild-type levels of Igμ (mRNA and protein), and this is associated with diminished signals, as measured by phosphorylation of pre-BCR/BCR downstream signaling proteins. Providing Eμ-deficient mice with a preassembled VL gene led not only to a larger immature B cell compartment but also to a decrease in "double-producers," suggesting that H chain/L chain combinations with superior signaling properties can overcome the signaling defect associated with low Igμ-chain and can eliminate the selective advantage of "double-producers" that achieve higher Igμ-chain levels through expression of a second IgH allele. Finally, we found that "double-producers" in Eμ-deficient mice include a subpopulation with autoreactive BCRs. We infer that BCRs with IgH chain from the Eμ-deficient allele are ignored during negative selection owing to their comparatively low density. In summary, these studies show that Eμ's effect on IgH levels at the pre-B cell to immature B cell transition strongly influences allelic exclusion, the breadth of the mature BCR repertoire, and the emergence of autoimmune B cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24058175      PMCID: PMC3810302          DOI: 10.4049/jimmunol.1301858

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  95 in total

1.  Targeted disruption of mu chain membrane exon causes loss of heavy-chain allelic exclusion.

Authors:  D Kitamura; K Rajewsky
Journal:  Nature       Date:  1992-03-12       Impact factor: 49.962

2.  B cell development under the condition of allelic inclusion.

Authors:  E Sonoda; Y Pewzner-Jung; S Schwers; S Taki; S Jung; D Eilat; K Rajewsky
Journal:  Immunity       Date:  1997-03       Impact factor: 31.745

3.  L chain allelic inclusion does not increase autoreactivity in lupus-prone New Zealand Black/New Zealand White mice.

Authors:  Efi Makdasi; Dan Eilat
Journal:  J Immunol       Date:  2013-01-14       Impact factor: 5.422

4.  Interaction between the immunoglobulin heavy chain 3' regulatory region and the IgH transcription unit during B cell differentiation.

Authors:  Zhongliang Ju; Sanjukta Chatterjee; Barbara K Birshtein
Journal:  Mol Immunol       Date:  2011-09-25       Impact factor: 4.407

Review 5.  The IgH locus 3' regulatory region: pulling the strings from behind.

Authors:  Eric Pinaud; Marie Marquet; Rémi Fiancette; Sophie Péron; Christelle Vincent-Fabert; Yves Denizot; Michel Cogné
Journal:  Adv Immunol       Date:  2011       Impact factor: 3.543

6.  A hypomorphic IgH-chain allele affects development of B-cell subsets and favours receptor editing.

Authors:  Sven Brenner; Diana Drewel; Thomas Steinbart; Florian Weisel; Eric Härtel; Sonja Pötzsch; Heike Welzel; Andreas Brandl; Philipp Yu; Geert C Mudde; Astrid Schweizer; Lars Nitschke; Thomas H Winkler
Journal:  EMBO J       Date:  2011-05-27       Impact factor: 11.598

7.  RAG-1-deficient mice have no mature B and T lymphocytes.

Authors:  P Mombaerts; J Iacomini; R S Johnson; K Herrup; S Tonegawa; V E Papaioannou
Journal:  Cell       Date:  1992-03-06       Impact factor: 41.582

8.  Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death.

Authors:  S B Hartley; M P Cooke; D A Fulcher; A W Harris; S Cory; A Basten; C C Goodnow
Journal:  Cell       Date:  1993-02-12       Impact factor: 41.582

9.  STIM1, PKC-δ and RasGRP set a threshold for proapoptotic Erk signaling during B cell development.

Authors:  Andre Limnander; Philippe Depeille; Tanya S Freedman; Jen Liou; Michael Leitges; Tomohiro Kurosaki; Jeroen P Roose; Arthur Weiss
Journal:  Nat Immunol       Date:  2011-03-27       Impact factor: 25.606

10.  Dual-reactive B cells are autoreactive and highly enriched in the plasmablast and memory B cell subsets of autoimmune mice.

Authors:  Emilie M Fournier; Maria-Gabriela Velez; Katelyn Leahy; Cristina L Swanson; Anatoly V Rubtsov; Raul M Torres; Roberta Pelanda
Journal:  J Exp Med       Date:  2012-08-27       Impact factor: 14.307

View more
  4 in total

1.  The 3'-Jα Region of the TCRα Locus Bears Gene Regulatory Activity in Thymic and Peripheral T Cells.

Authors:  Martina Kučerová-Levisohn; Stefan Knirr; Rosa I Mejia; Benjamin D Ortiz
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

2.  Multiple factors influence the contribution of individual immunoglobulin light chain genes to the naïve antibody repertoire.

Authors:  Sean P Fitzsimmons; Antonina G Aydanian; Kathleen J Clark; Marjorie A Shapiro
Journal:  BMC Immunol       Date:  2014-10-30       Impact factor: 3.615

3.  The IgH 3' regulatory region governs μ chain transcription in mature B lymphocytes and the B cell fate.

Authors:  Alexis Saintamand; Pauline Rouaud; Armand Garot; Faten Saad; Claire Carrion; Christelle Oblet; Michel Cogné; Eric Pinaud; Yves Denizot
Journal:  Oncotarget       Date:  2015-03-10

4.  Long-read sequencing unveils IGH-DUX4 translocation into the silenced IGH allele in B-cell acute lymphoblastic leukemia.

Authors:  Liqing Tian; Ying Shao; Stephanie Nance; Jinjun Dang; Beisi Xu; Xiaotu Ma; Yongjin Li; Bensheng Ju; Li Dong; Scott Newman; Xin Zhou; Patrick Schreiner; Elizabeth Tseng; Ting Hon; Meredith Ashby; Chunliang Li; John Easton; Tanja A Gruber; Jinghui Zhang
Journal:  Nat Commun       Date:  2019-06-26       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.